Root Financial Partners’s Eton Pharmaceutcials ETON Stock Holding History

Root Financial Partners’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$51	Buy	+1	New	+$51	﹤0.01%	3718

Other funds holding ETON

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Root Financial Partners's ETON Position: Q3 2026 in Review

Root Financial Partners opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 1 share worth $51. The stake represents ﹤0.01% of the portfolio and ranks #3718 among its holdings.

104 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

Root Financial Partners held 1 share of Eton Pharmaceutcials worth $51 as of Q3 2026.
Eton Pharmaceutcials was a new Root Financial Partners position in Q3 2026.
Eton Pharmaceutcials made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3718 holding.
104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.